A new study about adverse reactions to metal debris after Metal on Metal THR and Hip Resurfacing shows the current follow-up guidelines worldwide are not cost effective or evidence-based.
The follow-up guidelines for metal-on-metal (MoM) hip arthroplasty and hip resurfacing from five worldwide authorities worldwide, including the U.K. were included.
Findings showed large differences between cost per patients. U.S. costs were three-times more than MHRA costs…
…Australia vs. U.S. and Canada guidelines were about six-times more costly for asymptomatic patients.